Introduction

Treat Assets as One's Own, Innovate Continuously

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 688236.SH/01858.HK), established in 1998, is a leading orthopedic medical device manufacturer in China, specializing in the research, development, production, and sales of high-end implants and surgical instruments. The company holds 174 Class II or above medical device product registration certificates in China, with core products covering a comprehensive range of orthopedic series, including joints, spine, sports medicine, and trauma. It is actively expanding into cutting-edge fields such as dentistry, PRP preparation systems, orthopedic power systems, and surgical robots. While maintaining a leading position in the domestic market, the company is actively exploring international markets. Its hip, knee, spine, and other product series have obtained CE certification and U.S. FDA 510(K) approval, with their technological level receiving international recognition. The products are sold in 68 countries and regions worldwide. The company boasts a multidisciplinary R&D team covering fields such as mechanical engineering, materials science, biomechanics, and clinical medicine, and operates innovation platforms, including a National Enterprise Technology Center and a National Postdoctoral Research Station. It has been recognized as the first "National Manufacturing Single Champion Enterprise" with artificial joint prostheses as its main business and has received multiple qualifications, such as National High-Tech Enterprise, National Specialized, Refined, Distinctive, and Innovative "Little Giant" Enterprise, and National Intellectual Property Advantage Enterprise. The company is deeply involved in national-level scientific research projects, with three materials it spearheaded in tackling key challenges successfully included in the first list of the "Biological Medical Material Innovation Mission Unlocking Initiative." Chunli Medical adheres to the quality principle of "Treating products as if for personal use, continuously innovating," committed to overcoming core key technologies in the industry, promoting independent innovation in the orthopedic field, and striving to become a globally influential, high-quality medical device enterprise.

TOP.1

Single Champion in Artificial Joint Prosthesis Manufacturing

68
+个
产品远销国家和地区

Products Exported toGlobal Markets

6000
+
产品遍布全国医院

Products CoverHospitals Nationwide

174

Class II+ Medical DeviceRegistration Certificate

1156
拥有专利

Patent

424
授权发明专利

Invention patent

13
国际PCT专利

International PCT Patent

14
软件著作权

Software Copyright

7
国际首创产品

Internationally Pioneering Products

2
国内首家上市产品

Monograph in the Publishing Industry

29
国家及省部级重点公关项目

National & Provincial Key R&D Projects

24
国家标准、行业标准、团体标准

National 、industry 、group standards

Corporate Culture

Corporate Mission

Deliver safe, effective products for global orthopedic patients.

Corporate Vision

Lead medical device frontier with top quality .

Core values

Uphold Quality, Integrity.

Pursue Lean Pragmatism, Probity.

Champion Learning , Win-Win Cooperation

Quality Policy

Treat Assets as One's Own,

Innovate Continuously.

History

--
February 1998
Beijing Chunlizhengda R&D Co., Ltd. was established in Beijing.
2000
Obtained the Company's First Registration Certificate (CL Series Hip Prosthesis) Issued by NMPA.
2001
Certified to the GB/T 19000-2000 Medical Device Quality Management System.
2003年
The company's registered address has been moved to Tongzhou District, Beijing.
2009
Certified as a National High-Tech Enterprise;
Obtained the EU CE Class III Medical Device Certification;
"Chunli Sunshine Program" Co-Established with China Charity Federation Officially Launched.
2010
Completed the shareholding system reform and officially renamed Beijing Chunlizhengda Medical Instruments Co., Ltd.
2012
Obtained the Medical Device Export Sales Certificate of the People's Republic of China.
2014
Establishment of China's First Government-Authorized "Beijing Artificial Joint Engineering Laboratory".
2015
Listed on the Main Board of HKEX, Stock Code: 01858.HK.
2016
Recognized as a G20 Innovation-Leading Enterprise during China's 13th Five-Year Plan.
2018
Approved as a National Postdoctoral Research Station;
Construction Commenced on Daxing New Base.
2019
Recognized as Beijing Enterprise Technology Center;
Approved as an Academician-Expert Workstation.
2020
13th Five-Year Plan Key R&D Program "Porous Tantalum Bone Repair & Implant Products" Approved.
2021
Formal Launch of SCFJ Orthopedic R&D Transformation & Training Center;
First Biological Hip Tumor Surgery Launched in the Middle East;
Domestic Debut of Unicompartmental Knee with Mobile & Fixed Platforms;
Grand Launch of China's First Patellofemoral Joint Product;
Approval of MIIT "Yangtze INS-1 Orthopedic Navigation Robot" Project.
2021
Chunli Medical listed on SSE STAR Market, China's first A+H orthopedic device firm.
2022
Accredited as a National Enterprise Technology Center;
Designated as a Beijing Intellectual Property Model Unit;
Certified as a National "Little Giant" Enterprise (Specialized, Refined, Featured, Innovative);
Approved: National Key R&D Program "High-Quality Medical Metal Implants";
"New Axis Knee Prosthesis" Wins China Patent Excellence Award.
2023
China's First Toe Joint Prosthesis Approved for Marketing;
"Hip Prosthesis - Zirconium-Niobium Ball Head" (from Chunli Medical's Postdoctoral Research Station) Approved for Marketing;
MIIT "Champion Application" Projects: Degradable Medical Mg Alloy, Medical AM Tantalum Powder, Biphasic CaP Approved;
13th Five-Year Plan National Key R&D Program Project Successfully Concluded.
2023
Certified as a National Intellectual Property Advantage Enterprise;
Completed the Acquisition of Shujie Medical.
2024
Awarded the National "Manufacturing Single Item Champion" Title;
Awarded the China Nonferrous Metals Industry Science and Technology Award;
"Yangtze INS-1 Hip Arthroplasty Handheld Robot" Approved for Marketing;
Selected into MIIT's "AI Medical Device Innovation Task Champion List".

2025
Chunli Medical was listed on the "2025 Beijing Advanced Smart Factory" ranking;
Chunli Medical received the "Top Ten Surgical Robot Innovation Products" certificate;
Chunli Medical was shortlisted in the Beijing 2025 First Batch of First (Set) Major Technology Equipment Catalog;
Chunli Medical was awarded the "Beijing New Technologies, New Products, and New Services" certificate;
Chunli Medical won the First Prize for Innovative Technology at the 2025 China Simulation Society Science and Technology Awards;
Chunli Medical was shortlisted in the 2025 Ministry of Industry and Information Technology's Artificial Intelligence Medical Device Innovation Mission Unlocking Initiative.

Address

No. 10, Xinmixi 2nd Road, South Area of Tongzhou Economic

Development Zone, Tongzhou District, Beijing City, P.R. China

Contact Number

010-80561677

Talent Recruitment

hr@clzd.com

International Email

feedback@clzd.com

Custom Feedback

chunlidingzhi@clzd.com

Social media

版权所有 © 2025 北京市春立正达医疗器械股份有限公司 京ICP备19036045号

技术支持: